Alnylam Pharmaceuticals, Inc.
ALNY
$251.56
$8.953.69%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -3.08% | 5.93% | 10.68% | -2.79% | 1.38% |
| Total Receivables | 14.54% | 14.34% | -3.70% | -1.96% | 0.72% |
| Inventory | 3.32% | -9.52% | -10.65% | 5.43% | -6.92% |
| Prepaid Expenses | -19.53% | -6.07% | -23.38% | 59.80% | -19.99% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -1.79% | 5.75% | 6.17% | 0.20% | -0.09% |
|
|
|||||
| Total Current Assets | -1.79% | 5.75% | 6.17% | 0.20% | -0.09% |
| Net Property, Plant & Equipment | -1.35% | -1.69% | -0.48% | -0.95% | -0.45% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 71.51% | 20.52% | 3.82% | -3.74% | -2.53% |
| Total Assets | 0.83% | 4.87% | 4.84% | -0.14% | -0.24% |
|
|
|||||
| Total Accounts Payable | 24.87% | -4.29% | -5.33% | 40.76% | -24.81% |
| Total Accrued Expenses | -15.96% | 17.01% | 15.71% | 6.74% | -8.18% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 16.77% | 28.03% | 17.96% | -8.97% | 12.59% |
| Total Finance Division Other Current Liabilities | 108.07% | 2.93% | -10.20% | -52.28% | 108.76% |
| Total Other Current Liabilities | 108.07% | 2.93% | -10.20% | -52.28% | 108.76% |
| Total Current Liabilities | -2.82% | 15.68% | 12.06% | -2.69% | 1.90% |
|
|
|||||
| Total Current Liabilities | -2.82% | 15.68% | 12.06% | -2.69% | 1.90% |
| Long-Term Debt | 0.06% | -0.33% | 0.28% | 0.67% | 0.53% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.75% | -1.39% | 0.64% | -2.17% | -1.86% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 11.05% | 1.60% | -30.20% | 1.79% | 4.15% |
| Total Liabilities | 0.01% | 3.99% | -0.77% | -0.17% | 1.14% |
|
|
|||||
| Common Stock & APIC | 1.77% | 1.93% | 3.50% | 1.04% | 1.10% |
| Retained Earnings | -1.16% | -1.57% | -0.24% | -0.94% | -2.01% |
| Treasury Stock & Other | -39.04% | 28.33% | -28.34% | -15.46% | 27.72% |
| Total Common Equity | 107.36% | 1,154.91% | 98.60% | 0.62% | -33.03% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 107.36% | 1,154.91% | 98.60% | 0.62% | -33.03% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 107.36% | 1,154.91% | 98.60% | 0.62% | -33.03% |
|
|
|||||